(Q46157390)

20 December 2017

title

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease (English)

1 reference

20 December 2017

0 references

1 reference

3

1 reference

20 December 2017

Shitij Kapur

10

1 reference

20 December 2017

Oleh Hornykiewicz

7

object named as

Oleh Hornykiewicz

1 reference

20 December 2017

author name string

Isabelle Boileau

1

1 reference

20 December 2017

Mark Guttman

2

1 reference

20 December 2017

John R Adams

4

1 reference

20 December 2017

Sylvain Houle

5

1 reference

20 December 2017

Junchao Tong

6

1 reference

20 December 2017

Yoshiaki Furukawa

8

1 reference

20 December 2017

Alan A Wilson

9

1 reference

20 December 2017

Stephen J Kish

11

1 reference

20 December 2017

language of work or name

English

0 references

publication date

19 January 2009

1 reference

20 December 2017

published in

Brain

1 reference

20 December 2017

volume

132

1 reference

20 December 2017

issue

Pt 5

1 reference

20 December 2017

page(s)

1366-1375

1 reference

20 December 2017

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine agonist monotherapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Kinetics of the uptake and distribution of the dopamine D(2,3) agonist (R)-N-[1-(11)C]n-propylnorapomorphine in brain of healthy and MPTP-treated Göttingen miniature pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Exact and approximate rebinning algorithms for 3-D PET data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Pathological gambling caused by drugs used to treat Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release and [3H]spiperone binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Boredom proneness--the development and correlates of a new scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Effects of the putative dopamine D3 receptor antagonist PNU 99194A on motor behavior and emotional reactivity in C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

A New Anatomical Framework for Neuropsychiatric Disorders and Drug Abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

What has been learnt from study of dopamine receptors in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and L-DOPA treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

D3 receptor expression within the basal ganglia is not affected by Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Micro topography of Tyrosine Hydroxylase, Glutamic Acid Decarboxylase, and Choline Acetyltransferase in the Substantia Nigra and Ventral Tegmental Area of Control and Parkinsonian Brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine D3 receptor agonists for protection and repair in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Antiparkinsonian medication and pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

The Mechanism of Action of Novel Antipsychotic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Functional imaging in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Detecting dementia with the mini-mental state examination in highly educated individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

An automated method for the extraction of regional data from PET images

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine receptors labelled by PHNO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

D3 dopamine receptor mRNA is widely expressed in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Plasticity of the nigropallidal pathway in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWN337

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWN337

1 reference

20 December 2017

1 reference

20 December 2017